MXPA00005088A - Antiperspirant or deodorant compositions - Google Patents
Antiperspirant or deodorant compositionsInfo
- Publication number
- MXPA00005088A MXPA00005088A MXPA/A/2000/005088A MXPA00005088A MXPA00005088A MX PA00005088 A MXPA00005088 A MX PA00005088A MX PA00005088 A MXPA00005088 A MX PA00005088A MX PA00005088 A MXPA00005088 A MX PA00005088A
- Authority
- MX
- Mexico
- Prior art keywords
- antiperspirant
- deodorant
- composition
- weight
- active
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 79
- 239000002781 deodorant agent Substances 0.000 title claims abstract description 30
- 230000001166 anti-perspirant Effects 0.000 title claims abstract description 25
- 239000003213 antiperspirant Substances 0.000 title claims abstract description 25
- 235000021324 borage oil Nutrition 0.000 claims abstract description 18
- 239000010474 borage seed oil Substances 0.000 claims abstract description 15
- 210000003491 Skin Anatomy 0.000 claims description 12
- 239000000969 carrier Substances 0.000 claims description 12
- 239000002537 cosmetic Substances 0.000 claims description 12
- 229920001296 polysiloxane Polymers 0.000 claims description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 239000002562 thickening agent Substances 0.000 claims description 7
- QCWXUUIWCKQGHC-UHFFFAOYSA-N zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 claims description 3
- 229910052726 zirconium Inorganic materials 0.000 claims description 3
- 210000004243 Sweat Anatomy 0.000 claims 1
- 230000001147 anti-toxic Effects 0.000 claims 1
- -1 aluminium-zirconium Chemical compound 0.000 abstract description 17
- 229910052782 aluminium Inorganic materials 0.000 abstract description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminum Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 abstract description 6
- 239000004411 aluminium Substances 0.000 abstract 1
- 230000001668 ameliorated Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 14
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 150000001298 alcohols Chemical class 0.000 description 11
- 229940044550 gamma-Linolenic Acid Drugs 0.000 description 11
- 229960002733 gamolenic acid Drugs 0.000 description 11
- VZCCETWTMQHEPK-QNEBEIHSSA-N γ-Linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 11
- 239000000463 material Substances 0.000 description 10
- 239000003974 emollient agent Substances 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 241001072256 Boraginaceae Species 0.000 description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N Palmitic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 6
- QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 6
- 239000000443 aerosol Substances 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 150000002430 hydrocarbons Chemical class 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 239000005871 repellent Substances 0.000 description 5
- 230000002940 repellent Effects 0.000 description 5
- 239000000600 sorbitol Substances 0.000 description 5
- 235000010356 sorbitol Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- NNPPMTNAJDCUHE-UHFFFAOYSA-N Isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 4
- 150000002170 ethers Chemical class 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 150000002191 fatty alcohols Chemical class 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 230000002209 hydrophobic Effects 0.000 description 4
- 239000001282 iso-butane Substances 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 150000003754 zirconium Chemical class 0.000 description 4
- 235000007689 Borago officinalis Nutrition 0.000 description 3
- 235000021314 Palmitic acid Nutrition 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000000845 anti-microbial Effects 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 210000000245 Forearm Anatomy 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N Linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N Oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 231100000494 adverse effect Toxicity 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 2
- NNCOOIBIVIODKO-UHFFFAOYSA-N aluminum;hypochlorous acid Chemical class [Al].ClO NNCOOIBIVIODKO-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 230000003078 antioxidant Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- IJDNQMDRQITEOD-UHFFFAOYSA-N butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 2
- 239000001273 butane Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 201000004624 dermatitis Diseases 0.000 description 2
- 231100000406 dermatitis Toxicity 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000002335 preservative Effects 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 229940063655 Aluminum stearate Drugs 0.000 description 1
- 206010003246 Arthritis Diseases 0.000 description 1
- WURBFLDFSFBTLW-UHFFFAOYSA-N Benzil Chemical group C=1C=CC=CC=1C(=O)C(=O)C1=CC=CC=C1 WURBFLDFSFBTLW-UHFFFAOYSA-N 0.000 description 1
- 239000004135 Bone phosphate Substances 0.000 description 1
- 241000722877 Borago Species 0.000 description 1
- 240000004355 Borago officinalis Species 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L Calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229940107161 Cholesterol Drugs 0.000 description 1
- 230000037250 Clearance Effects 0.000 description 1
- 240000005497 Cyamopsis tetragonoloba Species 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N Dodecanol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 240000004478 Eleusine coracana Species 0.000 description 1
- 235000013499 Eleusine coracana subsp coracana Nutrition 0.000 description 1
- 210000003743 Erythrocytes Anatomy 0.000 description 1
- 229940065521 Glucocorticoid inhalants for obstructive airway disease Drugs 0.000 description 1
- 206010019233 Headache Diseases 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- QWTDNUCVQCZILF-UHFFFAOYSA-N Isopentane Chemical compound CCC(C)C QWTDNUCVQCZILF-UHFFFAOYSA-N 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- XAPRFLSJBSXESP-UHFFFAOYSA-N Oxycinchophen Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=C(O)C=1C1=CC=CC=C1 XAPRFLSJBSXESP-UHFFFAOYSA-N 0.000 description 1
- 229940026235 PROPYLENE GLYCOL MONOLAURATE Drugs 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene (PE) Substances 0.000 description 1
- 229920002413 Polyhexanide Polymers 0.000 description 1
- 229940096055 Prax Drugs 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O Pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
- 208000008742 Seborrheic Dermatitis Diseases 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 208000006641 Skin Disease Diseases 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N Stearyl alcohol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- 229940037128 Systemic Glucocorticoids Drugs 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N THP Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- HWKQNAWCHQMZHK-UHFFFAOYSA-N Trolnitrate Chemical compound [O-][N+](=O)OCCN(CCO[N+]([O-])=O)CCO[N+]([O-])=O HWKQNAWCHQMZHK-UHFFFAOYSA-N 0.000 description 1
- 229940099259 Vaseline Drugs 0.000 description 1
- DUNKXUFBGCUVQW-UHFFFAOYSA-J Zirconium(IV) chloride Chemical compound Cl[Zr](Cl)(Cl)Cl DUNKXUFBGCUVQW-UHFFFAOYSA-J 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002730 additional Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N al2o3 Chemical class [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- DVBBEGGVSYJLME-UHFFFAOYSA-N aluminum;hydrochloride Chemical class [Al].Cl DVBBEGGVSYJLME-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000003712 anti-aging Effects 0.000 description 1
- 230000000844 anti-bacterial Effects 0.000 description 1
- 230000002576 anti-transpirant Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000001204 arachidyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- DHAZIUXMHRHVMP-UHFFFAOYSA-N butyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCC DHAZIUXMHRHVMP-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000035512 clearance Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000003247 decreasing Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- LLRANSBEYQZKFY-UHFFFAOYSA-N dodecanoic acid;propane-1,2-diol Chemical compound CC(O)CO.CCCCCCCCCCCC(O)=O LLRANSBEYQZKFY-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drugs Drugs 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 150000002194 fatty esters Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 101700037660 ina-1 Proteins 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 230000003522 irritant Effects 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical class [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N palmityl palmitate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propanol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N rac-1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 235000002079 ragi Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 150000003334 secondary amides Chemical class 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 230000001953 sensory Effects 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-M stearate Chemical compound CCCCCCCCCCCCCCCCCC([O-])=O QIQXTHQIDYTFRH-UHFFFAOYSA-M 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 125000002640 tocopherol group Chemical group 0.000 description 1
- 229930003799 tocopherols Natural products 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 230000036572 transepidermal water loss Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
- IPCAPQRVQMIMAN-UHFFFAOYSA-L zirconyl chloride Chemical compound Cl[Zr](Cl)=O IPCAPQRVQMIMAN-UHFFFAOYSA-L 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N β-Sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
Abstract
Deodorant and antiperspirant compositions can suffer from perceived irritancy when applied topically, which can be ameliorated or overcome by incorporating within the composition borage seed oil, and especially an amount selected in the range of from 0.5 to 10 wt.%. The compositions advantageously comprise an aluminium or aluminium-zirconium active.
Description
ANTITRANSPIRANT OR DEODORANT COMPOSITIONS
DESCRIPTION OF THE INVENTION The invention relates to compositions ant i t ran spi ran t e s or deodorants. In particular, it relates to compositions of antimicrobials or deodorants comprising borage seed oil. The antiperspirant market is referred to by products based on aluminum or zirconium salts which are intended to prevent, or at least control, transiration on the surface of the skin, particularly in the underarms, since they frequently provide a perceived degree of deodorant. In contrast, deodorants are formulations which are designed to hide odor or prevent their formation by reducing the local population of microorganisms. The antiperspirant and deodorant compositions are used in many product applications, for example, pellets, creams, sticks, aerosols, pumping sprinklers. However all applications suffer from a number of disadvantages as well.
A major disadvantage of many deodorants and antiperspirants is their unfavorable perception on the skin. More particularly, the presence of volatile carriers such as ethanol and volatile silicones, and of course the deodorants and the titranspirant actives are perceived as well as a multitude of other ingredients commonly used in deodorant and antiperspirant formulations that have a adverse effect, in particular an irritant effect, on the user's skin followed by the application. Irritation can be alleviated by decreasing the amount of an active ingredient in the composition or by reducing the penetration of the active substance through the skin. A serious disadvantage of both approaches is that efficiency is affected. Adverse effects discourage many consumers from using deodorants and antiperspirants, thus depriving the consumer of the benefits derived from such cosmetics. An object of the invention is to provide a composition having excellent deodorant or anti-oxidant performance, excellent cosmetic and aesthetic properties with reduced irritation or without irritation. European Patent Application 0416855 (Efamol) describes the treatment of skin damage due to radiotherapy with gamma linolenic acid (GLA) also teaches a variety of suitable plant sources of GLA, including Borage species. PCT application WO 90/07331 (Went) teaches the treatment of inflammation arising from arthritis or headache by local application of GLA; Borage seed is taught as an adequate source. European Patent Application 0173478 (Efamol) describes the treatment of skin flammable disorders with compositions containing GLA and glucocorticoids; Borage species such as B or r a go or f f i c i n a l e s are mentioned as a rich source of GLA. French Patent 2,704,390 (Boiron) discloses an oral supplement containing borage seed oil to provide anti-aging benefits to the skin, French Patent 2,604,624 (Parfums Rochas) discloses skin care compositions containing polyunsaturated carboxylic acids , such as GLA; It is said that borage is rich in GLA. U.S. Patent 5,445,822 (Braceo) describes cosmetic compositions containing polyunsaturated acids such as 1 GLA. British Patent 2,271,928 (Laing) describes the use of plant extracts from the borage family for the relief of skin disorders and irritations. Tollesson et al., "Transepidermal Water Loss and Water Content in the Stratum Corneum in Infatué Sebhorreic Dermatitis", Derm Venereol Act (Sweden), Feb. 1993, 73 (1), p. 18-20 describes the use of locally applied borage oil for the treatment of seborrheic dermatitis. Bahemer et al. , "Treatment of Atopic Dermatitis with Borage Seed Oil (Glandol) - A Time Series Analytic Study", Kinderarztl Prax (Germany), Oct. 1992, 60 (7), p. 199-202, describes the use of borage oil for the treatment of local dermatitis. The technique does not teach the use of GLA or borage seed oil to reduce the irritation or itching associated with the use of deodorants or antiperspirants. It was found that among the plant sources containing GLA, borage seed oil was particularly effective in relieving irritation and that this effect can not be attributed merely to the presence of GLA in borage seed oil. It was also found that borage seed oil was more effective than any other plant that does not contain GLA. Surprisingly, it has been found that borage seed oil can be incorporated into a cosmetic composition of anti-oxidant deodorant to produce a composition having attractive and improved cosmetic characteristics, expected from such compositions as well as excellent efficiency, low potential irritation and without stinging by the application. According to the invention there is provided a cosmetic deodorant composition or a n t i t r ansp r an t suitable for local application to human skin, comprising: i. an active deodorant or antiperspirant; ii. a carrier for the antiperspirant or deodorant active; and iii. borage seed oil. Wherein the formulation is an antiperspirant which commonly comprises 1-35% by weight of the composition of an antiperspirant active. Borage seed oil is obtained from the seeds of the borage plant, also known as Borago of fie ina 1 is L. (Bo ragi na ce ae), which is an annual herbaceous plant, native to Europe, Asia Minor and North Africa, naturalized in the United States. The oil seed contains two: gamma linolenic acid (GLA), -24% sterols (for example, peastrol and sitosterol), tocopherols, linoleic acid (-38%), oleic acid (-14.5-23%), palmitic acid (-4.7) %), amabilina, etc. See Whipkey et al., "In Vivo and In Vitro Lipid Accumulation in Borago officinalis L", JAOCS, 65 (6), 979-984 (1988); and Leung al., "Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics," 2nd ed. , John Wiley & Sons, Inc., New York (1996). The borage seed oil is used in accordance with the present invention to reduce or eliminate skin irritation and / or stinging caused by co-composing of the antiperspirant or deodorant composition according to the invention. The amount of borage seed oil in the inventive compositions generally ranges from at least 0.05%, preferably from 0.1% to 20%, more preferably from 0.5% to 10%. In some compositions it is convenient to use a concentration of up to 5% by weight as well as 0.5 to 1% by weight. An antiperspirant composition according to the invention comprises an antiperspirant active. Examples of suitable active ingredients include aluminum salts, zirconium salts, aluminum and / or zirconium complexes, for example aluminum halides, aluminum oxides of aluminum, zirconium oxyalides, hydrogen peroxide and zirconium oxides. and mixtures thereof. Specific examples include activated aluminum chlorohydrate, aluminum chlorohydrate, p e n a c 1 or r h i dr a t of aluminum and zirconium aluminum chlorihydrate. Useful zirconium salts include zirconium or zirconium and zirconium oxychloride. Other assets generally used will be known to those skilled in the art. Preferred assets include AAZG (Glycine of C i r coni or -Al umi n i o
Activated), ZAG (Glycine Al uminoC i r conio) and AACH
(Activated Aluminum Hydrochloride). The antiperspirant antimicrobial active may be present in the form of a particle or in a solution such as, for example, in aqueous solution, advantageously 30 to 60% by weight of the solution. The amount of antiperspirant active present in the composition according to the invention can be 1-35- by weight of the composition, preferably 10-30% by weight and more preferably 20-30% by weight of the composition. compo si ci on. The deodorant compositions according to the invention typically comprise from 0.01 to 90% of a deodorant active. The deodorant active used in the cosmetics of the invention can be any deodorant active known in the art such as alcohols, in particular aliphatic monohydric alcohols such as ethanol or propanol, antimicrobial actives such as polyhexamethylenebiguanides for example CosmocilTlí or chlorinated aromatics for example Triclosan ™, non-chemical deodorant assets such as the treatment, bactericides and bacteriostats. The carrier material for the composition of the title according to the invention may also comprise one or more of the volatile carrier fluids, one or more of the non-volatile emollients, and if one or a combination of thickener is required. and / or structuring materials. The carrier material, which includes, where relevant, carrier materials that provide additional properties such as emolliency, can often comprise up to about 90% by weight of the composition, in many cases from 5 to 80% by weight and particularly 10% by weight. up to 70% by weight. Where the composition comprises both hydrophilic and hydrophobic phases, the weight ratio of the two phases is often in the range of 10: 1 to 1:10. The aerosol compositions according to the present invention may be obtained by conveniently introducing a base formulation as described herein, which is free of repellent and at least 0.7 times and often 1.5 to 20 times its weight of repellent within a spray-suitable spray. The antiperspirant or deodorant composition may comprise a mixture of particulate solids or a suspension of solids in a liquid medium, which may be thickened to reduce the rate of segregation or structured to produce a cream (soft solid) or solid. Alternatively The composition may comprise a mixture of constituent liquids, including a solution of an active in a carrier, such composition often taking the form of an oil in water or water in oil emulsion, which may be thickened or gel-like. The carrier material, which may be a fluid or a mixture of fluids, is often selected according to the physical form of the cosmetic composition, for example volatile silicones of low viscosity, low molecular weight hydrocarbons, alcohols with the Except for etansl, and water, and can be selected by those skilled in the art to provide appropriate sensory and physical properties for the product. Volatile silicones are usually selected from cyclic polysiloxanes containing from 3 to 8 dialkyl silicon groups, especially dimeric groups, and particularly from 4 or 5 dimethyl groups with. Other useful volatile silicones may comprise linear or linear units, preferably containing 4 or 5 groups at 1 qui 1 s and 1 oxane, including terminal groups. Low molecular weight liquid hydrocarbons may comprise paraffin oils. Suitable alcohols may comprise monihydric alcohols, such as C3 aliphatic alcohols up to CIO, dihydric alcohols such as glycol or propylene glycol or polyhydric alcohols such as glycerol or sorbitol. The carrier materials can provide additional desirable properties, such as polyhydric alcohols for example glycerol can act as a wetting agent and volatile cytomenes can act as emollients. If used in the composition, the non-volatile emollient may consist of a simple emollient compound or a mixture of emollients, and may typically include fatty alcohols and esters of fatty alcohols, alcohols and esters slightly soluble in water, hydrocarbons, insoluble ethers in water, mineral oils and polyorganosiloxanes, and mixtures thereof. The non-volatile silicones are frequently polyaclysiloxanes, for example the 1-oxime, 1-oxides or 1-oxides having a viscosity above 10 mPa.s, such as up to about 5 × 10 4 mPa.s up to 25 ° C, including 1 ime ti 1 f eni 1 if 1 oxano or ether copolymer of dime ti Ip or 1 i oxy to l ene i.
Aliphatic ester emollients often contain about 12 to 25 carbons, and preferably a substituent containing a chain of at least 2 carbons. Examples include cetyl palmitate, butyl myristate, glyceryl stearate and propylene glycol monolaurate. The composition may comprise a liquid aliphatic ether which can provide emolliency, such as the ethers derived from polyalkylene glycols and a low weight alcohol (for example up to C6), such as pol ip r op i 1 engl i col. { 10-15) butyl ether. The total amount of emollient materials within the composition, which exclude borage oil, is frequently within the range of 1 to 70% by weight. The structuring agent or thickener, when required, is selected according to the product form of the cosmetic composition. The structuring agent or thickener may be organic (numerical or polymeric) or inorganic and is usually chosen depending on the physical nature of the liquid phase that is to be thickened or stretched, such as when it is • hydrophobic or hydrophilic. The amount is usually selected to obtain the desired viscosity or the liquid or cream of the desired strength to penetrate a solid according to the present invention. It can be any of a number of materials, including, for example, waxed structurants for a hydrophobic phase or composition including hydrogenated vegetable oil, hydrogenated castor oil, fatty acids, such as hydroxy acid, beeswax, beeswax. , paraffin wax, microcrystalline waxes, silicone wax, and fatty acids and fatty alcohols such as stearyl alcohol. Polymeric materials for thickening include polymers such as polyamides, hydroxypropyl cellulose, and synthetic or natural gums, such as pyridinium, including agar, agarose, pectin, or guars or mixtures or combinations thereof. An additional class of polymers which is particularly directed to the structuring of an oil phase containing a silicone oil comprises polysiloxane elastomers. Suspending agents such as silica or clays such as bentonite, mon tmo r i 11 on i t a or hectorite, include those available under the trademark Bentona which can also be used to thicken liquid compositions according to the invention.
The composition can be thickened with non-polymeric organic gelatins, including selected dibenzoyl alditols- (eg dibenzoyl sorbitol) or selected n-acylamino derivatives (eg N-acyl glutamide derivatives) or selected hydroxy fatty acids (eg 12-hi acid) dr ox iest ea ri co) or sterols (for example cholesterol) or secondary amides selected by di or tribasic carboxylic acids, (for example 2-dode cy 1-N, N'-dibuti 1 s ucc in imide) by themselves or in combination. The amount of structuring agent or thickener to be employed in the compositions of the invention will depend on the viscosity of a fluid formulation or the hardness amplification of a solid formulation that the producer wishes to achieve. The amount to be employed will vary in practice also depending on the chemical nature of the structuring agent or thickener. In many cases, the amount of structuring agent or thickener will be selected in the range of 0.1 to 20% by weight and particularly 1 to 15% by weight. The composition according to the invention may optionally comprise other ingredients, in addition to those already identified, depending on the nature and form of the finished product. Other ingredients common to the art can also be included in the compositions according to the invention. These include surfactants, fillers, fragrances, preservatives and coloring agents for example. These ingredients are selected according to the physical and chemical form of the composition of the chemical. The surfactants may optionally comprise up to 25%, more commonly up to 5% by weight of the total product, and are particularly useful in formulating antiperspirant or deodorant emulsion compositions for example for use as pump or pellet spray formulations. However for other types of product, it is preferred that the composition contains less than about 8% is weight of surfactants. Nonionic surfactants are particularly preferred. It is often convenient to select a mixture of surfactants, such as one having a comparatively high value of HLB, for example from 8 to 18, and one having a comparatively low value of HLB, for example from 2 to 8, which can introduced into suitable relative proportions to obtain an average HLB value of about 6 to 12. Many suitable non-ionic surfactants are selected from nonionic esters, ethers or amine oxides having an appropriate value of HLB. Many preferred ionic surfactants comprise a 1-oxo-1-alkyl-1-ene molecule, especially a polyoxyethylene molecule, for example from 2 to 80, especially from 5 to 60 oxyethylene units, or possibly with an oxygen content. op i 1 e no, to provide a hydrophilic condition. Other molecules that provide a hydrophilic condition include polyhydric alcohols such as sorbitol or glycerol. The hydrophobic molecule is commonly derived from aliphatic alcohols or acids or amines containing from about 8 to 50 carbons and particularly from 10 to 30 carbons. Examples of suitable nonionic surfactants include ceteareth-10 to -25, cetet-10-25, e s t ert e-10-25, and PEG-15-25 stearate or distearate. Other suitable examples include mono, di or triglycerides of C 10 -C 20 fatty acids. Additional examples include ethers of C18-C22 fatty alcohols of polyethylene oxides (from 8 to 12 EO). Examples of surfactants that typically have a low value of HLB, and often 2 to repeatedly, comprise mono or possibly fatty acid diesters of polyhydric alcohols such as glycerol, sorbitol, erythrocyte or primate, including cetyl, arachidyl and behenyl stearyl. Other examples include monoglycerides of palmitic or stearic acid, sorbitol mono or diesters of myristic, palmitic or stearic acid and monoesters of triethyl ether or stearic acid. The fillers can comprise up to about 20%, more commonly up to 10% of the total product and are usually less expensive than the essential components of the invention; which reduces the total cost. Suitable fillers include aluminum stearate, aluminum tristearate, calcium stearate, talc or finely divided polyethylene, an example of which is ACUMIST B18. Fragrances, when present typically comprise up to about 1% of the total product.
The coloring agents and preservatives can be added as desired. Other optional ingredients are other cosmetics adjuncts conventionally employed in antiperspirant products or deodorants. The ingredients that can optionally be present in the composition of the carrier can conveniently form the balance of the composition. The repellents commonly employed in the aerosol compositions herein comprise hydrocarbons (or much less desirably halohydrides) having a boiling point below 10 ° C and especially those with a boiling point below 0 ° C. . It is especially preferred to employ liquefied hydrocarbon gases and specifically C3 to C4 hydrocarbons, including propane, isopropane, butane, isobutane, pentane and isopentane and mixtures of two or more thereof. The preferred repellents are isobutane, isobutane / isoprone, objectate / pr ope and mixtures of isopropane, isobutane and butane. The composition according to the invention can take any form of a product suitable or adapted for local application of human skin, and is usually contained in a suitable bra or dispenser to allow it to be applied to the skin area, particularly in the armpits, where control of ranspiration and deodorization is required.
Example 1 Twenty healthy male and female volunteers who were between the ages of 18 and 55 were recruited for each trial.
Patch Tests The patches consisted of a divided strip of Al-test units (Finn chambers of 0.8 cm internal diameter) are fixed on top of a wide Scanpor occlusive tape manufactured by Ñor ge sp 1 a s t e r, Norway. Ten compartments were used in these studies to contain the ten test samples.
Test Procedure The protocol adopted for these studies was double-blind, within the type of subject comparison. Twenty volunteer volunteers were conducted per test.
It is a condition of safe clearance of the patch test in the armpit that the panelists have a "rest period" of 3 weeks before a site in the armpit can be repaired.
Protocol The arms were prepared by placing a small amount of Vaseline (White Petroleum Jelly ex Boots) in the lower part of each test chamber, followed by a filter paper on which the test material was dosed. One drop of each test product was dosed back onto a filter paper using a 1.0 ml plastic Pástete pipette supplied by Orme scientific. This constituted an average dose of approximately 0.02g. In the case Jel aerosol product was sprayed directly onto the filter paper (in a ventilated spray booth) and the filter paper was then inserted into the appropriate chamber Finn immediately before patching (the average dose of the aerosol was estimated from the results of 20 filter papers so saturated, the products were randomly put through the patch sites. "The panelists were instructed to keep the patches clean and dry while they are in. The panelists reported on Monday morning of the week. When they had the application of a patch to the clean skin of an inner forearm, these patches remained in place for 24 hours when the panelists were again reported and removed the patch.They returned 6 hours later for evaluation of each one. of the patch sites, the newly prepared patches were applied using the same random distribution of the product. in place for 18 hours, the panelists reported another ez and the patch was removed; again the patches were classified 6 hours later. This r epa rc e and f i ca tion was repeated on Thursday and Friday. A final recovery reading is carried out the following Tuesday morning- that is to say 5 classifications were made in total. The readings six hours after the final removal of the patch were of the greatest interest. A potential issue with this protocol (highlighted during the secure free space process) was "the tape reaction" due to the multiple application and removal of the tape from the same site of the forearm. Therefore the degree of reaction to the tape was also recorded using the same rating scale as that used for the patch sites. The marker for each test was classified according to the Patch Rating Scale.
The marker for each sample was averaged to produce a final marker.
Patch Classification Scale
Resul ados
The normal statistical analysis showed that sample 2 was significantly milder than sample 1 and that sample 4 was significantly milder than sample 3.
Example 2 The following is an antiperspirant stick formulation according to the invention. It can be done by normal methods known in the art.
(1) Comprising 24% AZAG; 1% ESTOL E04DS; 4% Castor Wax; 14% Lorol C 18 deo; 3.2% talc;
1% perfume; and 52.8% DC345 volatile silicone. (2) Comprising 10% AACH; 1% Bentona 38; 1.0% perfume; 13% volatile silicone Q2 1465 and 75% repellent.
E xemployment 3 The following is an antiperspirant aerosol formulation according to the invention. It can be done by normal methods known in the art.
Claims (6)
1. Deodorant or antiperspirant cosmetic composition suitable for local application to human skin comprising: i. an active deodorant or against sweat; ii. a carrier for deodorant or antiperspirant active; and iii. borage seed oil.
2. Composition according to claim 1, characterized in that it comprises from 0.1 to 20% and preferably from 0.5 to 10% by weight of the borage seed oil.
3. Composition according to claim 1 or 2, characterized in that they comprise from 10 to 30% by weight of the active antitoxin agent.
4. Composition according to any preceding claim characterized in that the antiperspirant active contains zirconium.
5. Composition according to any preceding claim characterized in that it comprises a volatile silicone carrier, preferably in an amount of 10 to 70% by weight.
6. Composition according to any preceding claim, characterized in that it comprises a structuring agent or thickener in a concentration sufficient to produce a bar or a r ema.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9724802.5 | 1997-11-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA00005088A true MXPA00005088A (en) | 2001-07-03 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2589449C (en) | Underarm cosmetic method and compositions comprising a skin darkening inhibition system | |
US6086887A (en) | Antiperspirant or deodorant | |
RU2523898C2 (en) | Antiperspirant/deodorant composition | |
MXPA06014680A (en) | Antiperspirant compositions comprising ozokerite. | |
BRPI0904268A2 (en) | cosmetic process of perfuming a keratically human matter, aqueous perfuming composition, compositions and cosmetic process of treatment of body odors | |
EP0957897B1 (en) | Antiperspirant or deodorant compositions | |
AU2012101815A4 (en) | Anhydrous antiperspirant compositions | |
US10729627B2 (en) | Anhydrous antiperspirant compositions | |
AU602039B2 (en) | Cosmetic product | |
ES2924128T3 (en) | deodorant products | |
KR20160075356A (en) | Antiperspirant composition | |
EA020750B1 (en) | Malodor reduction of cosmetic products | |
WO2016094974A1 (en) | Anhydrous antiperspirant composition comprising vegetable oil | |
MXPA00005088A (en) | Antiperspirant or deodorant compositions | |
WO2022000050A1 (en) | Anhydrous deodorant cosmetic composition, process of manufacturing the anhydrous deodorant cosmetic composition and use of the anhydrous deodorant cosmetic composition | |
EA032891B1 (en) | Antiperspirant compositions comprising alums | |
WO2023280776A1 (en) | Emulsion antiperspirant compositions | |
WO2014088586A1 (en) | Antiperspirant/deodorant cosmetic compositions | |
EP3908247A1 (en) | An antiperspirant composition comprising inorganic polyionic cluster |